This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering every area of thoracic pathology, it incorporates the most recent clinical, pathologic, and molecular knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice. Succinctly written, richly illustrated, and easy to use, Diagnostic Pathology: Thoracic, fourth edition, is an essential text for accurate diagnosis and ideal as a day-to-day reference or as a one-stop resource for surgical pathologists, pathology residents, and fellows.
- Provides a clear framework for a better understanding of the clinical and histopathologic findings of pulmonary, pleural, and mediastinal entities; as well as an intuitive structure that organizes chapters by neoplastic and nonneoplastic lesions and pseudotumoral conditions of the lung
- Offers major additions to the molecular pathology sections for all relevant entities, specifying the types of genetic mutations found in those tumors, covering next-generation sequencing and other molecular diagnostic techniques, and detailing the ways these genetic alterations can be used by pathologists to distinguish diseases
- Features new chapters on lung allograft pathology; pulmonary chondroma in Carney syndrome; new soft tissue tumor entities, including clear cell stromal tumor of the lung; and new salivary gland tumors, including hyalinizing clear cell carcinoma
- Contains timely updates for mesothelioma grading, squamous cell carcinoma grading, and thymic epithelial tumor diagnostics, including new information on thymic carcinoma; new additions to atypical and conventional thymoma; updated content on molecular genetics of thymic tumors; and new molecular genetic and diagnostic biomarker details for several bone and soft tissue chapters, including nomenclature and classification changes for certain soft tissue tumors
- Features updated criteria and classification of interstitial lung disease based on the 2025 International Multidisciplinary Classification of Interstitial Pneumonias from the American Thoracic Society (ATS) and European Respiratory Society (ERS)
- Provides important updates that reflect the 2026 World Health Organization (WHO) Classification of Lung Tumors as well as the 2026 molecular testing guidelines from the College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and International Association for the Study of Lung Cancer (IASLC)
- Features a templated, highly formatted design and concise, bulleted text; diagnostic pearls, a Key Facts summary in every chapter; and an extensive index for easy reference
- Contains nearly 3,000 high-quality print images (with an additional 900+ images in the complimentary eBook), including gross pathology, radiology, and histology images, and full-color medical illustrations-all carefully annotated to help you quickly recognize established entities
- Includes a complimentary eBook with everything in the print version as well as additional text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud; additional digital ancillary content may publish up to 6 weeks following the publication date
Table of Contents
PART I: LUNGSection 1: Neoplasms, Benign
Section 2: Other Rare Tumors and Benign Pseudotumoral Conditions
Section 3: Neoplasms, Malignant, Primary
ADENOCARCINOMA
Adenocarcinoma Variants
SQUAMOUS CELL CARCINOMA
NEUROENDOCRINE CARCINOMA AND PRECURSOR LESIONS
POORLY DIFFERENTIATED NON-SMALL CELL CARCINOMAS
SALIVARY GLAND-TYPE TUMORS
MESENCHYMAL NEOPLASMS
LYMPHOPROLIFERATIVE DISORDERS
OTHER NEOPLASMS
Section 4: Neoplasms, Metastatic
Section 5: Nonneoplastic and Systemic Conditions
Section 6: Infectious Diseases
PARASITIC
FUNGAL
BACTERIAL
VIRAL
PART II: PLEURA
Section 1: Benign Tumors and Reactive Conditions
Section 2: Neoplasms, Malignant, Primary
MESOTHELIAL NEOPLASMS
OTHER MALIGNANT NEOPLASMS
PART III: MEDIASTINUM
Section 1: Benign Tumors and Reactive Conditions
Section 2: Neoplasms, Malignant, Primary
EPITHELIAL NEOPLASMS
GERM CELL TUMORS
HEMATOPOIETIC MALIGNANCIES
MESENCHYMAL NEOPLASMS
SYMPATHETIC NERVOUS SYSTEM TUMORS
Authors
David I. Suster Associate Professor, Director, Surgical Pathology, Department of Pathology, Rutgers University, New Jersey Medical School, Newark, New Jersey. Dr. Suster received his medical doctorate from the Tulane University School of Medicine, New Orleans, Louisiana, followed by pathology residency training in anatomic and clinical pathology at Beth Israel Deaconess Medical Center, Harvard Medical School, in Boston, Massachusetts. This was followed by a Selective Pathology fellowship at Massachusetts General Hospital, Harvard Medical School, where he focused on thoracic and bone and soft tissue pathology. He then completed a second fellowship in Molecular Genetic Pathology at Mount Sinai Hospital, Icahn School of Medicine, New York, New York. Dr. Suster is board certified in Anatomic, Clinical, and Molecular Genetic Pathology.Dr. Suster is the author of more than 50 original peer-reviewed manuscripts as well as 7 book chapters. He also is the coauthor of 2 books on thoracic pathology. His work is centered mainly in the field of thoracic and bone and soft tissue pathology. He has also contributed to the literature in areas of skin tumors, thyroid pathology, breast pathology, gynecological pathology, and others. He has had the opportunity to present locoregional as well as international lectures primarily on the topics of thoracic and bone and soft tissue pathology, and is currently working on multiple projects related to those fields. He currently serves as Associate Professor and Director of Surgical Pathology in Department of Pathology at Rutgers University, New Jersey Medical School, in Newark, New Jersey Mari Mino-Kenudson Professor of Pathology, Harvard Medical School, Division Chief of Anatomic Pathology for Mass General Brigham, Director of Pulmonary Pathology Service, Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts. Dr. Mino-Kenudson is Professor of Pathology at Harvard Medical School and Director of Pulmonary Pathology and a pathologist at Massachusetts General Hospital and Division Chief of Anatomic Pathology for Mass General Brigham. She is also Director of Pulmonary Pathology Service with the Department of Pathology at Massachusetts General Hospital in Boston, Massachusetts. Dr. Mino-Kenudson is board-certified in anatomic pathology and signs out specimens from the gastrointestinal tract, liver, pancreas, biliary tree, lung, and pleura. She also serves as a frozen section pathologist by reviewing intraoperative consultation specimens and communicating with surgeons. Her clinical interests include the classification and personalized medicine in the field of lung cancer, and malignant and premalignant lesions of the pancreas, especially intraductal papillary mucinous neoplasm (IPMN). Saul Suster Professor and Chairman Emeritus, Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin. Dr. Suster is Professor and Chairman Emeritus with the Department of Pathology at the Medical College of Wisconsin in Milwaukee, Wisconsin. He is a senior faculty member in the division of Anatomic Pathology. Dr. Suster was recently named in U.S. News & World Report's Top Doctors List for 2012-2013 and is among the top 1 % of Pathologists in the nation. Dr. Suster has also ranked for the past 5 years in Castle Connolly's "America's Top Doctors" and "America's Top Doctors for Cancer", as well as being listed in" Who's who in America."
